12:00 AM
Jan 28, 2013
 |  BC Week In Review  |  Company News  |  Other News

Pernix Therapeutics generics news

Pernix reduced its combined sales headcount by about 62 (33%) to about 125 following the integration of generics company Cypress Pharmaceutical Inc. and...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >